Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intraperitoneal chemotherapy

M Markman1

  • 1Department of Hematology/Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, OH 44195, USA. markmam@cesmtp.ccf.org

Critical Reviews in Oncology/Hematology
|October 26, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in Discounting Behavior and Brain Responses for Food and Money Reward.

eNeuro·2024
Same author

Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.

Annales de cardiologie et d'angeiologie·2021
Same author

Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.

European journal of gynaecological oncology·2018
Same author

Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Current oncology (Toronto, Ont.)·2018
Same author

Surgical intervention in relapsed ovarian cancer is beneficial: contra.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus Chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
See all related articles